ARCHIVES

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

NTP Establishes Panel To Write New Guidelines For Detection, Evaluation Of Chemical Carcinogens

April 1, 1983

The Lancet Oncology Issues “Expression Of Concern” Over Paper

July 23, 2010

NIH Issues Interim Guidelines For Research Using fetal Tissue

March 26, 1993

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

NCI Program: Hughes Institute Official To Head Cancer Biology

July 23, 1999